Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Rose brings medical device leadership and commercialization expertise to the company as it prepares to enter into U.S. and European pivotal clinical trials of UroActive, the first smart automated ...

Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, ...

I would now like to turn over the call to Mr. Kevin Lobo, Chair and Chief Executive Officer. You may proceed ... who will expand on our strategic rationale for the pending Inari acquisition. Jason ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Investing.com -- Inari Medical Inc (NASDAQ ... patients who suffer from peripheral vascular diseases,” said Stryker CEO Kevin Lobo. “These innovations elevate the standard of care for venous ...

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Full Year Results “We delivered another year of double-digit organic sales growth ...

U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...

Inari Medical Inc., one of Orange County’s fastest-growing medical ... saving solutions to patients who suffer from peripheral vascular diseases,” Stryker CEO Kevin Lobo said in a statement. “These ...

Inari Medical’s product portfolio includes medical ... of “innovative new solutions” and expand its footprint, Inari CEO Drew Hykes said in a news release. For the first nine months of ...